---
figid: PMC4618268__nihms-703863-f0001
figlink: /pmc/articles/PMC4618268/figure/F1/
number: F1
caption: 'RTK: receptor tyrosine kinase; EGFR: epidermal growth factor receptor; AR:
  androgen receptor. Activation of AKT and mTOR has been shown to feedback inhibit
  the activation, expression and signaling of a variety of RTKs, including members
  of the EGFR family, IGF1R, HER2/3 and others. Rapamycin-like drugs can relieve this
  feedback and activate RTKs, thereby attenuating the anti-tumor effect of these drugs.
  Inhibition of PI3K can activate AR through relief of negative feedback on RTK. Conversely,
  inhibition of AR activates AKT by reducing levels of the AKT phosphatase PHLPP.'
pmcid: PMC4618268
papertitle: 'Everolimus Combined With Gefitinib in Patients with Metastatic Castration-Resistant
  Prostate Cancer: Phase I/II Results and Signaling Pathway Implications.'
reftext: Dana E. Rathkopf, et al. Cancer. ;121(21):3853-3861.
pmc_ranked_result_index: '11118'
pathway_score: 0.9248849
filename: nihms-703863-f0001.jpg
figtitle: 'Everolimus Combined With Gefitinib in Patients with Metastatic Castration-Resistant
  Prostate Cancer: Phase I/II Results and Signaling Pathway Implications'
year: ''
organisms:
- Mus musculus
- Homo sapiens
ndex: 4755b2df-dea5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4618268__nihms-703863-f0001.html
  '@type': Dataset
  description: 'RTK: receptor tyrosine kinase; EGFR: epidermal growth factor receptor;
    AR: androgen receptor. Activation of AKT and mTOR has been shown to feedback inhibit
    the activation, expression and signaling of a variety of RTKs, including members
    of the EGFR family, IGF1R, HER2/3 and others. Rapamycin-like drugs can relieve
    this feedback and activate RTKs, thereby attenuating the anti-tumor effect of
    these drugs. Inhibition of PI3K can activate AR through relief of negative feedback
    on RTK. Conversely, inhibition of AR activates AKT by reducing levels of the AKT
    phosphatase PHLPP.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - MAPK3
  - AKT3
  - AKT1
  - MAPK1
  - MAPK13
  - MAPK12
  - FKBP5
  - MAPK10
  - ERBB3
  - IGF1R
  - PIK3R5
  - ERBB2
  - MAPK9
  - AKT2
  - AR
  - MAPK11
  - RICTOR
  - MTOR
  - RPTOR
  - PIK3CB
  - MAPKAP1
  - PHLPP1
  - PIK3R6
  - MAPK8
  - PIK3CD
  - PIK3R4
  - PIK3CA
  - MAPK14
  - PIK3CG
  - PIK3R3
  - RPS6KB1
  - MLST8
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: (FKBP5)
  symbol: FKBP5
  source: hgnc_symbol
  hgnc_symbol: FKBP5
  entrez: '2289'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Her2/3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: IGF1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Her2/3
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MTORC1/2
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1/2
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: PHLPP
  symbol: PHLPP
  source: hgnc_prev_symbol
  hgnc_symbol: PHLPP1
  entrez: '23239'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MTORC1/2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
chemicals: []
diseases: []
figid_alias: PMC4618268__F1
redirect_from: /figures/PMC4618268__F1
figtype: Figure
---
